Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-10-30

EMA Authorised: Elonva (corifollitropin alfa) — Organon N.V.

View source ↗

Summary

The European Medicines Agency has authorised Elonva (corifollitropin alfa) by Organon N.V. for use in assisted reproductive techniques and ovulation induction, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elonva (corifollitropin alfa)

Snippet

Status: Authorised. Therapeutic area: Reproductive Techniques, Assisted;Ovulation Induction;Investigative Techniques. MAH: Organon N.V.. Decision date: 30/10/2025